Procella Therapeutics AB

ABActive

Org 5590364609TullingeResearch and experimental development on natural sciences and engineering· NACE 7210Est. 2015 · 10 years old20-49 employees

Overview Financials People & ownership Related companies

Procella Therapeutics AB is a Swedish AB based in Tullinge, operating in the Research and experimental development on natural sciences and engineering sector. Incorporated in 2015, the company reported revenue of SEK 115M in its latest annual filing.

Revenue 2024

SEK 115M

-23% vs 2023

EBITDA margin

-4.1%

-136% vs 2023

Net profit 2024

SEK -18,3M

-2708% vs 2023

Key ratios

See full ratios →

26.9%

This company

20202024

0.3×

This company

20202024

-18.8%

This company

20202024

EBITDA — year on year

SEK millions

Key figures

Annual report 2024

Revenue	SEK 115M	-23%
EBITDA	SEK -4,7M	-136%
Net profit	SEK -18,3M	-2708%
Total assets	SEK 97,5M	-52%
Equity	SEK 26,2M	-23%
Employees	—	—

Contact

Address

Tullinge

oskar.steneryd@smartcella.com

Risika for professionals

Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.

Visit risika.com

Frequently asked questions

What is the Org number of Procella Therapeutics AB?

Procella Therapeutics AB is registered with Bolagsverket / SCB under Org 5590364609.

What is the revenue of Procella Therapeutics AB?

Procella Therapeutics AB reported revenue of SEK 115M in 2024.

Who is the CEO of Procella Therapeutics AB?

Niklas Prager is the CEO of Procella Therapeutics AB, in role since 2022.

Where is Procella Therapeutics AB headquartered?

Procella Therapeutics AB's registered address is Tullinge.

Procella Therapeutics AB

Key ratios

EBITDA — year on year

Key figures

Company information

Contact

Frequently asked questions

More on Procella Therapeutics AB

Key ratios

EBITDA — year on year

Key figures

Company information

Contact

Frequently asked questions

More on Procella Therapeutics AB